|
|
|
||||||||
 |
||||||||
| Sponsors | |
| Continuation of the Israel Penn International Transplant Tumor Registry is made possible with financial support from the following sponsors. | |
|
|
|
Fujisawa Healthcare, Inc., manufactures and markets proprietary pharmaceutical products in the transplantation, cardiovascular, anti-infective and dermatology therapeutic areas. Fujisawa's global mission to explore the frontiers of human health is underscored by the company's commitment and success in these specialized areas. Headquartered in Deerfield, Ill., Fujisawa is a wholly owned subsidiary of Fujisawa Pharmaceutical Co., Ltd., based in Osaka, Japan. Fujisawa Pharmaceutical, founded in 1894, is a leading international pharmaceutical manufacturer and is actively developing its operations not only in Japan but also on a global scale, particularly in North America, Europe and Asia. |
|
|
|
|
Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. prescription drug unit of the Roche Group, a leading research-based health care enterprise that ranks among the world's leaders in pharmaceuticals, diagnostics and vitamins. Roche discovers, develops, manufactures and markets numerous important prescription drugs that enhance people's health, well-being and quality of life. Among the company's areas of therapeutic interest are virology (including HIV/AIDS and hepatitis C), infectious diseases (including influenza), cardiology, neurology, oncology, transplantation, dermatology, and metabolic diseases (including obesity and diabetes). |
|
|
|
MedImmune, Inc. is a biotechnology company focused on developing and marketing products that address medical needs in areas such as infectious disease, immune regulation and cancer. Headquartered in Gaithersburg, Maryland, MedImmune has manufacturing facilities in Frederick, Maryland and Nijmegen, the Netherlands. |
|
|
|
Novartis Pharmaceuticals Corporation researches, develops, manufactures, and markets leading innovative prescription drugs used to treat a number of diseases and conditions in a variety of therapeutic areas including gastroenterology, central nervous system, organ transplantation, cardiology, dermatology, oncology, respiratory, and arthritis. The company's mission is to improve people's lives by pioneering novel healthcare solutions. |
|
|
|
Wyeth-Ayerst Laboratories, a division of American Home Products Corporation (NYSE:AHP), is a major research-oriented pharmaceutical company with leading products in the areas of transplantation, women's health care, cardiovascular therapies, central nervous system drugs, musculoskeletal therapies, infectious disease, hemophilia, oncology, vaccines, and generic pharmaceuticals. |
|
|
|
Copyright © 2007.
University of Cincinnati.
All Rights Reserved.
|
|